2-Hydroxy-5-(pyrrolidin-1-ylsulfonyl)benzoic acid

Catalog No. :
ACLSVH142
CAS No. :
326024-05-9
Molecular Formula :
C11H13NO5S
Molecular Weight :
271.29

IUPAC Name:2-hydroxy-5-(pyrrolidin-1-ylsulfonyl)benzoic acid

2-Hydroxy-5-(pyrrolidin-1-ylsulfonyl)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$136.00Login to see priceInquiryInquiry
1g95%$311.00Login to see priceInquiryInquiry
5g95%$912.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Hydroxy-5-(pyrrolidin-1-ylsulfonyl)benzoic acid
IUPAC Name2-hydroxy-5-(pyrrolidin-1-ylsulfonyl)benzoic acid
MDL No.MFCD02700702
Molecular FormulaC11H13NO5S
Molecular Weight271.29
SMILESO=C(O)C1=CC(S(=O)(N2CCCC2)=O)=CC=C1O
InChI KeyJQBNNVRJHMJMMK-UHFFFAOYSA-N
SynonymOprea1_007952;ZERO/006517;2-hydroxy-5-(pyrrolidin-1-ylsulfonyl)benzoic acid;2-hydroxy-5-1-pyrrolidinylsulfonylbenzoic acid;2-hydroxy-5-pyrrolidin-1-ylsulfonylbenzoic acid;2-hydroxy-5-pyrrolidin-1-ylsulfonyl-benzoic acid;Benzoic acid, 2-hydroxy-5-(1-pyrrolidinylsulfonyl)-
CAS No.326024-05-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLSVH142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQXM013 route compound structure diagram
    ACAQXM01317243-13-9 In Stock
  4. Then
  5. ACLSVH142 route product structure diagram
    ACLSVH142326024-05-9
Inquiry

2. ACLSVH142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLSVH142 route product structure diagram
    ACLSVH142326024-05-9
Inquiry

Comments (0)